These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24584997)

  • 1. Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.
    Alan S; Yildiz D; Erdeve O; Cakir U; Kahvecioglu D; Okulu E; Ates C; Atasay B; Arsan S
    Am J Perinatol; 2014 Dec; 31(12):1079-86. PubMed ID: 24584997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity.
    Kang CH; Tsai CM; Wu TH; Wu HY; Chung MY; Chen CC; Huang YC; Liu SF; Liao DL; Niu CK; Lee CH; Yu HR
    Pediatr Pulmonol; 2014 Apr; 49(4):381-8. PubMed ID: 23359527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].
    Celik IH; Demirel G; Tatar Aksoy H; Saygan S; Canpolat FE; Uras N; Oğuz SS; Erdeve O; Dilmen U
    Mikrobiyol Bul; 2011 Oct; 45(4):716-22. PubMed ID: 22090302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants.
    Ilhan O; Bor M; Ozdemir SA; Akbay S; Ozer EA
    Paediatr Drugs; 2018 Oct; 20(5):475-481. PubMed ID: 30073562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
    Garnacho-Montero J; Amaya-Villar R; Gutiérrez-Pizarraya A; Espejo-Gutiérrez de Tena E; Artero-González ML; Corcia-Palomo Y; Bautista-Paloma J
    Chemotherapy; 2013; 59(3):225-31. PubMed ID: 24356297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
    Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
    Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit.
    İşgüder R; Ağın H; Ceylan G; Bayram N; Devrim İ
    Am J Infect Control; 2016 Jun; 44(6):734-5. PubMed ID: 26921012
    [No Abstract]   [Full Text] [Related]  

  • 9. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
    Paksu MS; Paksu S; Karadag A; Sensoy G; Asilioglu N; Yildizdas D; Akyildiz BN; Kendirli T; Demirkol D; Akgun M; Alp E; Ciftci E; Guney AK; Murat N
    Int J Antimicrob Agents; 2012 Aug; 40(2):140-4. PubMed ID: 22727770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis.
    Wang J; Niu H; Wang R; Cai Y
    Int J Antimicrob Agents; 2019 Apr; 53(4):383-400. PubMed ID: 30447379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates.
    Al-Lawama M; Aljbour H; Tanash A; Badran E
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():8. PubMed ID: 26868136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
    Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Levin AS; Barone AA; Penço J; Santos MV; Marinho IS; Arruda EA; Manrique EI; Costa SF
    Clin Infect Dis; 1999 May; 28(5):1008-11. PubMed ID: 10452626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous colistin administration in neonates.
    Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
    Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
    Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
    Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
    J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired bartter-like syndrome associated with colistin use in a preterm infant.
    Cakir U; Alan S; Zeybek C; Erdeve O; Atasay B; Yalcinkaya F; Arsan S
    Ren Fail; 2013; 35(3):411-3. PubMed ID: 23342992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis.
    Rodríguez-Hernández MJ; Jiménez-Mejias ME; Pichardo C; Cuberos L; García-Curiel A; Pachón J
    Clin Microbiol Infect; 2004 Jun; 10(6):581-4. PubMed ID: 15191391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.